Incidence of New-Onset Atrial Fibrillation After TAVI

Evaluation of the Incidence of New-Onset Atrial Fibrillation After Aortic Valve Replacement
Findings:  In this population-based study, new-onset atrial fibrillation was present in roughly 50% of hospitalizations for transcatheter aortic valve implantation and aortic valve replacement. Hospitalizations with new-onset atrial fibrillation were associated with higher in-hospital mortality compared with transcatheter aortic valve implantation and aortic valve replacement hospitalizations without new-onset atrial fibrillation.

Meaning:  The high incidence of atrial fibrillation after transcatheter aortic valve implantation and aortic valve replacement should be discussed during the consent process and prompt shared patient-physician decision making regarding the potential need for anticoagulation after aortic valve procedures.

Author(s) Source
Kalra R, Patel N, Doshi R, et al. JAMA Intern Med. Published online June 3, 2019. doi:10.1001/jamainternmed.2019.0205
This is a post of a scientific or business information. The information given here is checked thoroughly by “Implant-Register”. However we can´t be responsible for the content. Contact the publisher, if you have questions. You may inform us about changes of the information to improve the Register.
Comments: n/a
let us know